Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

被引：0
|
作者：
Majd Issa
Brett G. Klamer
Nikol Mladkova
Georgios I. Laliotis
Vidhya Karivedu
Priyanka Bhateja
Chase Byington
Khaled Dibs
Xueliang Pan
Arnab Chakravarti
John Grecula
Sachin R. Jhawar
Darrion Mitchell
Sujith Baliga
Matthew Old
Ricardo L. Carrau
James W. Rocco
Dukagjin M. Blakaj
Marcelo Bonomi
机构：
[1] The Ohio State University Wexner Medical Center,Department of Internal Medicine, Division of Medical Oncology
[2] The Ohio State University,Center for Biostatistics, Department of Biomedical Informatics
[3] The Ohio State University Wexner Medical Center,Division of Radiation Oncology
[4] Johns Hopkins University,Sidney Kimmel Comprehensive Cancer Center and Department of Oncology
[5] The Ohio State University Wexner Medical Center,Department of Otolaryngology
来源：
BMC Cancer | / 22卷
关键词：
Head and neck cancer; Head and neck squamous cell carcinoma; Immunotherpay; Immune checkpoint inhibitors; Survival in head and neck cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery
    Dejaco, Daniel
    Steinbichler, Teresa
    Schartinger, Volker H.
    Fischer, Natalie
    Anegg, Maria
    Dudas, Jozsef
    Posch, Andrea
    Widmann, Gerlig
    Riechelmann, Herbert
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (04): : 728 - 739
  • [42] Validation and comparison of prognostic scoring systems in patients with head and neck squamous cell carcinoma treated with nivolumab
    Takenaka, Yukinori
    Takemoto, Norihiko
    Otsuka, Tomoyuki
    Nishio, Minako
    Tanida, Masashi
    Fujii, Takashi
    Hayashi, Kazuki
    Suzuki, Motoyuki
    Mori, Masashi
    Yamamoto, Yoshifumi
    Uno, Atsuhiko
    Inohara, Hidenori
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (07) : 761 - 769
  • [43] PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma
    Evrard, D.
    Hourseau, M.
    Couvelard, A.
    Paradis, V.
    Gauthier, H.
    Raymond, E.
    Halimi, C.
    Barry, B.
    Faivre, S.
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [44] Immune gene expression in head and neck squamous cell carcinoma patients
    Lecerf, Charlotte
    Kamal, Maud
    Vacher, Sophie
    Chemlali, Walid
    Schnitzler, Anne
    Morel, Claire
    Dubot, Coraline
    Jeannot, Emmanuelle
    Meseure, Didier
    Klijanienko, Jerzy
    Mariani, Odette
    Borcoman, Edith
    Calugaru, Valentin
    Badois, Nathalie
    Chilles, Anne
    Lesnik, Maria
    Krhili, Samar
    Choussy, Olivier
    Hoffmann, Caroline
    Piaggio, Eliane
    Bieche, Ivan
    Le Tourneau, Christophe
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 210 - 223
  • [45] The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck
    Hall, SF
    Groome, PA
    Rothwell, D
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2000, 22 (04): : 317 - 322
  • [46] Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Sakai, Akihiro
    Iijima, Hiroaki
    Ebisumoto, Koji
    Yamauchi, Mayu
    Teramura, Takanobu
    Yamazaki, Aritomo
    Watanabe, Takane
    Inagi, Toshihide
    Maki, Daisuke
    Okami, Kenji
    CANCERS, 2023, 15 (07)
  • [47] Age as a prognostic factor for head and neck squamous cell carcinoma: Should older patients be treated differently?
    Cinamon, U
    Hier, MP
    Black, MJ
    JOURNAL OF OTOLARYNGOLOGY, 2006, 35 (01) : 8 - 12
  • [48] Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
    Qiu, Yu
    Cui, Li
    Lin, Yang
    Gao, Bingju
    Li, Jun
    Zhao, Xinyuan
    Zhu, Xiaofeng
    Hu, Shen
    Lin, Lisong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Ultra-high combined positive score and high serum albumin are favorable prognostic biomarkers for immune checkpoint inhibitors in head and neck squamous cell carcinoma
    Saito, Yuki
    Kobayashi, Kenya
    Fukuoka, Osamu
    Sakai, Toshihiko
    Yamamura, Koji
    Ando, Mizuo
    Kondo, Kenji
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (02): : 367 - 377
  • [50] Prognostic 4-lncRNA-based risk model predicts survival time of patients with head and neck squamous cell carcinoma
    Xing, Lu
    Zhang, Xiaoqian
    Chen, Anwei
    ONCOLOGY LETTERS, 2019, 18 (03) : 3304 - 3316
12345